1
Clinical Trials associated with 4SCAR-CD44v6(Shenzhen Geno-Immune Medical Institute) / Unknown statusPhase 1/2IIT Multi-center Phase I/II Clinical Trial of 4SCAR-CD44v6 T Cells for Treating Cancer
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of 4SCAR-CD44v6 T-cell therapy targeting multiple cancers. The study also aims to learn more about the function of the CD44v6 CAR-T cells and their persistency in the patients.
100 Clinical Results associated with 4SCAR-CD44v6(Shenzhen Geno-Immune Medical Institute)
100 Translational Medicine associated with 4SCAR-CD44v6(Shenzhen Geno-Immune Medical Institute)
100 Patents (Medical) associated with 4SCAR-CD44v6(Shenzhen Geno-Immune Medical Institute)
100 Deals associated with 4SCAR-CD44v6(Shenzhen Geno-Immune Medical Institute)